Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma

Exclusion Criteria

• •Thrombocytopenia unrelated to chemotherapy during six months before screening, including but not limited to hypersplenism, infection and hemorrhage.
• •In addtion to CIT caused by lymphoma and chemotherapy,patients also suffer from other blood diseases including ALL, AML, myeloid neoplasms, MDS, myeloproliferative disorders, MM;
• •A thrombosis of a coronary artery or vein developed during three months before screening;
• •Haemorrhage with severe clinical symptoms, such as gastrointestinal and cerebral hemorrhage;
• •Platelet transfusion during two days before randomization;
• •Allergic to avatrombopag;
• •Participation in any other research about novel agents or devices;
• •Pregnant or breastfeeding women;
• •Researchers consider it unsuitable for patients to participate in this study.